OBJECTIVE: To evaluate the capabilities of photon counting spectral CT to differentiate components of coronary atherosclerotic plaque based on differences in spectral attenuation and iodine-based contrast agent concentration. METHODS: 10 calcified and 13 lipid-rich non-calcified histologically demonstrated atheromatous plaques from post-mortem human coronary arteries were scanned with a photon counting spectral CT scanner. Individual photons were counted and classified in one of six energy bins from 25 to 70 keV. Based on a maximum likelihood approach, maps of photoelectric absorption (PA), Compton scattering (CS) and iodine concentration (IC) were reconstructed. Intensity measurements were performed on each map in the vessel wall, the surrounding perivascular fat and the lipid-rich and the calcified plaques. PA and CS values are expressed relative to pure water values. A comparison between these different elements was performed using Kruskal-Wallis tests with pairwise post hoc Mann-Whitney U-tests and Sidak p-value adjustments. RESULTS: RESULTS for vessel wall, surrounding perivascular fat and lipid-rich and calcified plaques were, respectively, 1.19 ± 0.09, 0.73 ± 0.05, 1.08 ± 0.14 and 17.79 ± 6.70 for PA; 0.96 ± 0.02, 0.83 ± 0.02, 0.91 ± 0.03 and 2.53 ± 0.63 for CS; and 83.3 ± 10.1, 37.6 ± 8.1, 55.2 ± 14.0 and 4.9 ± 20.0 mmol l(-1) for IC, with a significant difference between all tissues for PA, CS and IC (p < 0.012). CONCLUSION: This study demonstrates the capability of energy-sensitive photon counting spectral CT to differentiate between calcifications and iodine-infused regions of human coronary artery atherosclerotic plaque samples by analysing differences in spectral attenuation and iodine-based contrast agent concentration. ADVANCES IN KNOWLEDGE: Photon counting spectral CT is a promising technique to identify plaque components by analysing differences in iodine-based contrast agent concentration, photoelectric attenuation and Compton scattering.
OBJECTIVE: To evaluate the capabilities of photon counting spectral CT to differentiate components of coronary atherosclerotic plaque based on differences in spectral attenuation and iodine-based contrast agent concentration. METHODS: 10 calcified and 13 lipid-rich non-calcified histologically demonstrated atheromatous plaques from post-mortem human coronary arteries were scanned with a photon counting spectral CT scanner. Individual photons were counted and classified in one of six energy bins from 25 to 70 keV. Based on a maximum likelihood approach, maps of photoelectric absorption (PA), Compton scattering (CS) and iodine concentration (IC) were reconstructed. Intensity measurements were performed on each map in the vessel wall, the surrounding perivascular fat and the lipid-rich and the calcified plaques. PA and CS values are expressed relative to pure water values. A comparison between these different elements was performed using Kruskal-Wallis tests with pairwise post hoc Mann-Whitney U-tests and Sidak p-value adjustments. RESULTS: RESULTS for vessel wall, surrounding perivascular fat and lipid-rich and calcified plaques were, respectively, 1.19 ± 0.09, 0.73 ± 0.05, 1.08 ± 0.14 and 17.79 ± 6.70 for PA; 0.96 ± 0.02, 0.83 ± 0.02, 0.91 ± 0.03 and 2.53 ± 0.63 for CS; and 83.3 ± 10.1, 37.6 ± 8.1, 55.2 ± 14.0 and 4.9 ± 20.0 mmol l(-1) for IC, with a significant difference between all tissues for PA, CS and IC (p < 0.012). CONCLUSION: This study demonstrates the capability of energy-sensitive photon counting spectral CT to differentiate between calcifications and iodine-infused regions of humancoronary artery atherosclerotic plaque samples by analysing differences in spectral attenuation and iodine-based contrast agent concentration. ADVANCES IN KNOWLEDGE: Photon counting spectral CT is a promising technique to identify plaque components by analysing differences in iodine-based contrast agent concentration, photoelectric attenuation and Compton scattering.
Authors: J P Schlomka; E Roessl; R Dorscheid; S Dill; G Martens; T Istel; C Bäumer; C Herrmann; R Steadman; G Zeitler; A Livne; R Proksa Journal: Phys Med Biol Date: 2008-07-08 Impact factor: 3.609
Authors: Ammar Sarwar; Johannes Rieber; Eline A Q Mooyaart; Sujith K Seneviratne; Stuart L Houser; Fabian Bamberg; O Christopher Raffel; Rajiv Gupta; Mannudeep K Kalra; Homer Pien; Hang Lee; Thomas J Brady; Udo Hoffmann Journal: Radiology Date: 2008-08-18 Impact factor: 11.105
Authors: Sebastian Feuerlein; Ewald Roessl; Roland Proksa; Gerhard Martens; Oliver Klass; Martin Jeltsch; Volker Rasche; Hans-Juergen Brambs; Martin H K Hoffmann; Jens-Peter Schlomka Journal: Radiology Date: 2008-10-10 Impact factor: 11.105
Authors: David P Cormode; Ewald Roessl; Axel Thran; Torjus Skajaa; Ronald E Gordon; Jens-Peter Schlomka; Valentin Fuster; Edward A Fisher; Willem J M Mulder; Roland Proksa; Zahi A Fayad Journal: Radiology Date: 2010-07-28 Impact factor: 11.105
Authors: Auranuch Lorsakul; Georges El Fakhri; William Worstell; Jinsong Ouyang; Yothin Rakvongthai; Andrew F Laine; Quanzheng Li Journal: J Med Imaging (Bellingham) Date: 2016-07-12
Authors: Rolf Symons; Tyler E Cork; Manu N Lakshmanan; Robert Evers; Cynthia Davies-Venn; Kelly A Rice; Marvin L Thomas; Chia-Ying Liu; Steffen Kappler; Stefan Ulzheimer; Veit Sandfort; David A Bluemke; Amir Pourmorteza Journal: Int J Cardiovasc Imaging Date: 2017-03-13 Impact factor: 2.357
Authors: Johoon Kim; Peter Chhour; Jessica Hsu; Harold I Litt; Victor A Ferrari; Rachela Popovtzer; David P Cormode Journal: Bioconjug Chem Date: 2017-05-18 Impact factor: 4.774